PhotoCure/Galderma Actinic Keratosis Phototherapy Clears FDA
This article was originally published in The Pink Sheet Daily
Executive Summary
The PhotoCure product, marketed as Metvix outside the U.S., will be launched by partner Galderma in “several weeks” following selection of an alternate tradename. The methyl aminolevulinate cream is used in combination with the CureLight activation lamp.
You may also be interested in...
Aldara Keratosis Approval
3M's Aldara supplemental NDA cleared FDA March 2 for the treatment of clinically typical, nonhyperkeratotic, nonhypertrophic actinic keratoses on the face or scalp in immunocompetent adults
Merck Tax Settlement Could Be Smaller Than GSK’s $3.4 Bil. IRS Deal
A possible settlement between Merck and tax authorities could be significantly smaller than GlaxoSmithKline's recent settlement with the IRS based on the companies' projected liability
McKindler? New Pfizer CEO Echoes McKinnell’s Views On Payers, Scale
Pfizer's success will depend on its ability to negotiate the paradox of increasing demand for pharmaceuticals coupled with growing attempts to restrain costs, CEO Jeffrey Kindler said